Literature DB >> 18331176

Inflatable penile prostheses for the treatment of erectile dysfunction: an update.

Bruce B Garber1.   

Abstract

Male erectile dysfunction (ED) is a common medical condition. Three oral medications (sildenafil, vardenafil and tadalafil, all phosphodiesterase type 5 inhibitors) have been developed and approved for the treatment of ED by the US FDA. Extensive worldwide marketing of these medications has raised public awareness of ED, and allowed many previously untreated men to seek and receive effective therapy. A variety of other ED treatments are available and approved by the FDA, including vacuum-constriction devices and intracavernous or intraurethral alprostadil. However, roughly 30-40% of men with ED are not adequately served by these treatments due to their cost, side effects, contraindications, the need to 'time' sexual activity, or lack of satisfactory erectile response. For men who do not respond to less invasive therapy, an inflatable penile prosthesis can provide a satisfying and effective alternative. This article will review and critique the inflatable penile prostheses that are currently available in the USA and the EU for the treatment of ED.

Entities:  

Mesh:

Year:  2008        PMID: 18331176     DOI: 10.1586/17434440.5.2.133

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

1.  A 3-piece penile prosthesis salvage in the presence of late-onset infected hematoma: Clinical, radiological and intraoperative findings-A case report.

Authors:  Moayid Fallatah; Manerh Bin Mosa; Ahmed Aljuhayman; Naif Alhathal
Journal:  Int J Surg Case Rep       Date:  2019-11-06

Review 2.  Preoperative counseling and expectation management for inflatable penile prosthesis implantation.

Authors:  Gopal L Narang; Bradley D Figler; Robert M Coward
Journal:  Transl Androl Urol       Date:  2017-11

3.  Simulation Training in Penile Implant Surgery: Assessment of Surgical Confidence and Knowledge With Cadaveric Laboratory Training.

Authors:  Aaron C Lentz; Dayron Rodríguez; Leah G Davis; Michel Apoj; B Price Kerfoot; Paul Perito; Gerard Henry; LeRoy Jones; Rafael Carrion; John J Mulcahy; Ricardo Munarriz
Journal:  Sex Med       Date:  2018-10-24       Impact factor: 2.491

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.